Fábio Leite Costa

Fábio Leite Costa

Auto-generated profile, based on publicly available information

Fábio Leite Costa

Faculdade de Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
AAAbel García Abejas
Abel García Abejas
ATAdrià Serra Trullás
Adrià Serra Trullás
MSMaria Ana Sobral
Maria Ana Sobral
Daniel CanelasDaniel Canelas
Daniel Canelas
FCFábio Leite Costa
Fábio Leite Costa
ÀVÀngels Salvador Verges
Àngels Salvador Verges
Background: Electronic patient-reported outcome measures (ePROMs) are essential to clinical practice and research. The growth of eHealth technologies has provided unprecedented opportunities to collect information systematically through ePROMs. Although they are widely used in scientific research, more evidence is needed to determine their use and implementation in daily clinical practice. For example, when diagnosed, patients with lung cancer are at an advanced stage of the disease. This entails tremendous burden because of high mortality and losses in the different dimensions of the human being. In this case, monitoring symptoms and other outcomes help improve the patient’s quality of life. Objective: ePROMs offered unprecedented opportunities to collect information systematically. Our goal was to demonstrate that ePROMs are more useful in controlling patient symptoms, lung cancer, and overall survival than their alternatives, such as nonelectronic PROMs. Methods: This exploratory review considered articles published between 2017 and 2022 identified through searches of PubMed, Scopus, Cochrane, CINAHL, and PsycINFO. We found 5097 articles; after removing the duplicates, we reduced them to 3315. After reading the summary, we were left with 56. Finally, after applying the exclusion criteria, we reviewed 12. The 5-step framework by Arksey and O’Malley was used to refine the initial search results with the following research questions: Do ePROMs help physician-patient communication? To what extent do they improve decision-making? Are institutions and their digitization policies barriers to or facilitators of this process? and What else is needed for routine implementation? Results: This review included 12 articles. We found that ePROMs are an integrative and facilitative communication tool, highlighting their importance in the relationship between palliative care and medical oncology. ePROMs help assess patient symptoms and functionality more accurately and facilitate clinical decision-making. In addition, it allows for more precise predictions of overall patient survival and the adverse effects of their treatments. The main institutional obstacles are the initial investment, which can be costly, and the data protection policy. However, enablers included better funding through the development of telemedicine, support from institutional leaders to overcome resistance to change, and transparent policies to ensure the safe and secure use of ePROMs. Conclusions: Routine collection of remote ePROMs is an effective and valuable strategy for providing real-time clinical feedback. In addition, it provides satisfaction to patients and professionals. Optimizing ePROMs in patients with lung cancer leads to a more accurate view of health outcomes and ensures quality patient follow-up. It also allows us to stratify patients based on their morbidity, creating specific follow-ups for their needs. However, data privacy and security are concerns when using ePROMs to ensure compliance with local entities. At least four barriers were identified: cost, complex programming within health systems, safety, and social and health literacy.

14 May 2025 in Interactive Journal of Medical Research
Verified
Journal Article
Open access
AAAbel García Abejas
Abel García Abejas
DSDavid Geraldes Santos
David Geraldes Santos
FCFabio Leite Costa
Fabio Leite Costa
ABAida Cordero Botejara
Aida Cordero Botejara
HMHelder Mota-Filipe
Helder Mota-Filipe
ÀVÀngels Salvador Vergés
Àngels Salvador Vergés
Background: Artificial intelligence (AI) is increasingly integrated into palliative medicine, offering opportunities to improve quality, efficiency, and patient-centeredness in end-of-life care. However, its use raises complex ethical issues, including privacy, equity, dehumanization, and decision-making dilemmas. Objective: We aim to critically analyze the main ethical implications of AI in end-of-life palliative care and examine the benefits and risks. We propose strategies for ethical and responsible implementation. Methods: We conducted an integrative review of studies published from 2020 to 2025 in English, Portuguese, and Spanish, identified through systematic searches in PubMed, Scopus, and Google Scholar. Inclusion criteria were studies addressing AI in palliative medicine focusing on ethical implications or patient experience. Two reviewers independently performed study selection and data extraction, resolving discrepancies by consensus. The quality of the papers was assessed using the Critical Appraisal Skills Programme checklist and the Hawker et al tool. Results: Six key themes emerged: (1) practical applications of AI, (2) communication and AI tools, (3) patient experience and humanization, (4) ethical implications, (5) quality of life perspectives, and (6) challenges and limitations. While AI shows promise for improving efficiency and personalization, consolidated real-world examples of efficiency and equity remain scarce. Key risks include algorithmic bias, cultural insensitivity, and the potential for reduced patient autonomy. Conclusions: AI can transform palliative care, but implementation must be patient-centered and ethically grounded. Robust policies are needed to ensure equity, privacy, and humanization. Future research should address data diversity, social determinants, and culturally sensitive approaches.

1 July 2025 in Family Medicine and Community Health
Verified
Journal Article
Open access
PDF file
FCFábio Leite Costa
Fábio Leite Costa
MBMiguel Barbosa
Miguel Barbosa
Introduction: Family physicians (FPs) provide essential support during life’s most challenging moments, including experiences of grief and loss. After a patient’s death, FPs are expected to provide information and emotional support to bereaved family members. Prior research suggests that bereaved relatives expect follow-up contact from their FP, acknowledging it as part of the physician’s role. This study aims to explore the practices and attitudes of FPs towards bereaved family members. Methods: A cross-sectional, descriptive study was conducted through an online questionnaire, exploring participants’ perceived role in bereavement care, the type of support offered to families, available resources in primary care, as well as personal knowledge and approach on grief. This questionnaire was distributed via digital platforms to general and family medicine doctors. Results: A total of 210 physicians participated (84.3% female; 53.8% in residency), with a median age of 32 years old. On average, each FP experienced five patient deaths, most often reported by family members. More than half (53.3%) contacted bereaved families in fewer than 25% of cases, typically within 7 days of the death, most commonly by phone (76.5%). Conclusion: This study highlights significant gaps in the bereavement follow-up practices of FPs in Portugal. Findings emphasise the need for integrated bereavement care guidelines in primary care, institutional policies and investment in targeted training programmes to enhance grief’s approach. The reported lack of grief training reinforces the need to integrate grief education into medical curriculum and continuous professional development. Structural improvements, such as the implementation of automatic death notifications within the healthcare system, are also critical for enabling timely and effective support.

28 July 2025 in BMJ Open Quality
Verified
Journal Article
Open access
AAAbel García Abejas
Abel García Abejas
JGJoão Marques Gomes
João Marques Gomes
MAMaria Eduarda Andrade
Maria Eduarda Andrade
Daniel CanelasDaniel Canelas
Daniel Canelas
MSMaria Ana Sobral
Maria Ana Sobral
ÀVÀngels Salvador Vergès
Àngels Salvador Vergès
Background: Patient-reported outcome measures (PROMs) are increasingly recognised as valuable tools for personalising care pathways and improving the quality of life for patients with lung cancer. PROMs capture patients’ perceptions of symptoms and functional status, while patient-reported experience measures focus on how patients perceive the care process, communication, empathy and accessibility. However, integrating PROMs into clinical practice remains challenging. This study explores physicians’ perceptions of PROMs in lung cancer care, their impact and the barriers and facilitators to their implementation. Objectives: This study seeks to understand physicians’ perspectives on the role of PROMs in enhancing the quality of life, dignity and autonomy of patients with lung cancer and to identify key barriers and facilitators to their integration into clinical practice. Methods: 16 semistructured interviews were conducted with physicians treating patients with lung cancer. A hybrid thematic analysis was used to identify key themes and patterns in the data. Results: Three main themes emerged: (1) patient-related factors, such as health literacy and emotional distress; (2) the influence of social and family environments and (3) the role of PROMs in clinical decision-making. While PROMs were valued for their potential to improve care, barriers like digital literacy and socioeconomic factors hindered their application. Specifically, the study found that while physicians valued the potential of PROMs to improve patient care, several barriers, including patients’ digital literacy and socioeconomic factors, hindered their practical application. Conclusions: PROMs offer a pathway to enhance patient-centred care in lung cancer treatment. However, their successful integration requires addressing barriers such as health literacy, digital access and multidisciplinary collaboration. Future research should focus on strategies for effective PROM integration into clinical workflows and investigate methods for effectively integrating PROMs into routine clinical workflows.

6 March 2025 in JMIR Preprints
Verified
Preprint
Open access
AAAbel García Abejas
Abel García Abejas
DSDavid Geraldes Santos
David Geraldes Santos
FCFabio Leite Costa
Fabio Leite Costa
ABAida Cordero Botejara
Aida Cordero Botejara
HMHelder Mota-Filipe
Helder Mota-Filipe
ÀVÀngels Salvador Vergés
Àngels Salvador Vergés
BACKGROUND Artificial intelligence (AI) is increasingly integrated into palliative medicine, offering opportunities to improve quality, efficiency, and patient-centeredness in end-of-life care. However, its use raises complex ethical issues, including privacy, equity, dehumanization, and decision-making dilemmas. OBJECTIVE We aim to critically analyze the main ethical implications of AI in end-of-life palliative care and examine the benefits and risks. We propose strategies for ethical and responsible implementation. METHODS We conducted an integrative review of studies published from 2020 to 2025 in English, Portuguese, and Spanish, identified through systematic searches in PubMed, Scopus, and Google Scholar. Inclusion criteria were studies addressing AI in palliative medicine focusing on ethical implications or patient experience. Two reviewers independently performed study selection and data extraction, resolving discrepancies by consensus. The quality of the papers was assessed using the Critical Appraisal Skills Programme checklist and the Hawker et al tool. RESULTS Six key themes emerged: (1) practical applications of AI, (2) communication and AI tools, (3) patient experience and humanization, (4) ethical implications, (5) quality of life perspectives, and (6) challenges and limitations. While AI shows promise for improving efficiency and personalization, consolidated real-world examples of efficiency and equity remain scarce. Key risks include algorithmic bias, cultural insensitivity, and the potential for reduced patient autonomy. CONCLUSIONS AI can transform palliative care, but implementation must be patient-centered and ethically grounded. Robust policies are needed to ensure equity, privacy, and humanization. Future research should address data diversity, social determinants, and culturally sensitive approaches.

4 February 2023 in JMIR Preprints
Verified
Preprint
Open access
AAAbel García Abejas
Abel García Abejas
ATAdrià Serra Trullás
Adrià Serra Trullás
MSMaria Ana Sobral
Maria Ana Sobral
Daniel CanelasDaniel Canelas
Daniel Canelas
FCFábio Leite Costa
Fábio Leite Costa
ÀVÀngels Salvador Verges
Àngels Salvador Verges
BACKGROUND Electronic patient-reported outcome measures (ePROMs) are essential to clinical practice and research. The growth of eHealth technologies has provided unprecedented opportunities to collect information systematically through ePROMs. Although they are widely used in scientific research, more evidence is needed to determine their use and implementation in daily clinical practice. For example, when diagnosed, patients with lung cancer are at an advanced stage of the disease. This entails tremendous burden because of high mortality and losses in the different dimensions of the human being. In this case, monitoring symptoms and other outcomes help improve the patient’s quality of life. OBJECTIVE ePROMs offered unprecedented opportunities to collect information systematically. Our goal was to demonstrate that ePROMs are more useful in controlling patient symptoms, lung cancer, and overall survival than their alternatives, such as nonelectronic PROMs. METHODS This exploratory review considered articles published between 2017 and 2022 identified through searches of PubMed, Scopus, Cochrane, CINAHL, and PsycINFO. We found 5097 articles; after removing the duplicates, we reduced them to 3315. After reading the summary, we were left with 56. Finally, after applying the exclusion criteria, we reviewed 12. The 5-step framework by Arksey and O’Malley was used to refine the initial search results with the following research questions: Do ePROMs help physician-patient communication? To what extent do they improve decision-making? Are institutions and their digitization policies barriers to or facilitators of this process? and What else is needed for routine implementation? RESULTS This review included 12 articles. We found that ePROMs are an integrative and facilitative communication tool, highlighting their importance in the relationship between palliative care and medical oncology. ePROMs help assess patient symptoms and functionality more accurately and facilitate clinical decision-making. In addition, it allows for more precise predictions of overall patient survival and the adverse effects of their treatments. The main institutional obstacles are the initial investment, which can be costly, and the data protection policy. However, enablers included better funding through the development of telemedicine, support from institutional leaders to overcome resistance to change, and transparent policies to ensure the safe and secure use of ePROMs. CONCLUSIONS Routine collection of remote ePROMs is an effective and valuable strategy for providing real-time clinical feedback. In addition, it provides satisfaction to patients and professionals. Optimizing ePROMs in patients with lung cancer leads to a more accurate view of health outcomes and ensures quality patient follow-up. It also allows us to stratify patients based on their morbidity, creating specific follow-ups for their needs. However, data privacy and security are concerns when using ePROMs to ensure compliance with local entities. At least four barriers were identified: cost, complex programming within health systems, safety, and social and health literacy.